IP Library Patent Application 13458697
Patent Application
App. No. 13/458,697

SELECTIVE STIMULATION TO MODULATE THE SYMPATHETIC NERVOUS SYSTEM

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/458,697
Abstract

Systems, methods and devices are provided for the targeted treatment of a variety of medical conditions by directly neuromodulating a target anatomy associated with the condition while minimizing or excluding undesired neuromodulation of other anatomies. Typically, the target anatomy includes one or more dorsal root ganglia, dorsal roots, dorsal root entry zones, or portions thereof. Such target stimulation areas are utilized due in part to their effect on the sympathetic nervous system.

Claims (27)

1 . A method of modulating a neural pathway in the sympathetic nervous system, comprising:

positioning at least one electrode of a lead in close proximity to a dorsal root ganglion upstream of at least one ganglion of the sympathetic nerve chain; and

providing energy to the at least one electrode so as to neuromodulate the dorsal root ganglion in a manner that influences a condition associated with the at least one ganglion of the sympathetic nerve chain while excluding neuromodulation of an associated ventral root.

2 . The method according to claim 1 wherein neuromodulating a dorsal root ganglion comprises neuromodulating a dorsal root ganglion in a manner that influences functional activation of a bodily system associated with the at least one ganglion along the sympathetic nerve chain.

3 . The method according to claim 2 wherein neuromodulating a dorsal root ganglion comprises neuromodulating a dorsal root ganglion in a manner that influences functional activation of an organ associated with the at least one ganglion along the sympathetic nerve chain.

4 . The method according to claim 1 wherein neuromodulating a dorsal root ganglion comprises neuromodulating a dorsal root ganglion in a manner that influences functional inhibition of a bodily system associated with the at least one ganglion along the sympathetic nerve chain.

5 . The method according to claim 4 wherein neuromodulating a dorsal root ganglion comprises neuromodulating a dorsal root ganglion in a manner that influences functional inhibition of an organ associated with the at least one ganglion along the sympathetic nerve chain.

6 . The method according to claim 1 wherein neuromodulating a dorsal root ganglion comprises neuromodulating a dorsal root ganglion in a manner that lessens vascular resistance of a blood vessel associated with the at least one ganglion along the sympathetic nerve chain.

7 . The method according to claim 1 wherein neuromodulating a dorsal root ganglion comprises neuromodulating a dorsal root ganglion in a manner that improves vascular perfusion to an ischemic body region or tissue.

8 . The method according to claim 1 wherein the condition comprises an ischemic disorder, diabetes, peripheral vascular disease, stroke, erectile dysfunction, a sympathetically maintained or mediate pain condition, Raynaud's disease, heart disease, angina pectoris, vascular disease, a skin ulceration, a wound healing disorder, asthma, hypertension, an immune system disorder or a renal disorder.

9 . The method according to claim 1 wherein the at least one ganglion of the sympathetic nerve chain is a cervical ganglion.

10 . The method according to claim 1 wherein the at least one ganglion of the sympathetic nerve chain is a thoracic ganglion.

11 . The method according to claim 1 wherein the at least one ganglion of the sympathetic nerve chain is a lumbar ganglion.

12 . The method according to claim 1 wherein the positioning step comprises positioning the at least one electrode on the dorsal root ganglion epinurium.

13 . The method according to claim 1 further comprising directly applying stimulation to the at least one ganglion along the sympathetic nerve chain.

14 . The method according to claim 13 wherein the directly applying stimulation step for the at least one ganglion along the sympathetic nerve chain is performed using an electrode exposed to the at least one ganglion along the sympathetic nerve chain.

15 . A method of modulating a portion of a neural pathway in the sympathetic nervous system, comprising:

positioning at least one electrode of a lead in close proximity to a target dorsal root ganglion associated with the portion of the neural pathway; and

energizing the at least one electrode so that the portion of the neural pathway is altered and energy provided by the at least one electrode dissipates within the target dorsal root ganglion while excluding an associated ventral root.

16 . A method as in claim 15 , wherein the energy provided by the at least one electrode selectively stimulates a soma and/or one of the ascending or descending axons within the target dorsal root ganglion which activates a premotor neuron.

17 . A method as in claim 16 , wherein the activation of the premotor neuron acts upon a sympathetic motor neuron causing inhibition of the release of norephinephrine by the sympathetic motor neuron.

18 . A method as in claim 16 , wherein the activation of the premotor neuron acts upon a sympathetic motor neuron causing inhibition of vascular resistance in a blood vessel influenced by the sympathetic motor neuron.

19 . A method as in claim 15 , wherein the altering of the portion of the neural pathway increases perfusion to a region of the body associated with the portion of the neural pathway.

20 . A method as in claim 19 , wherein the region of the body comprises a brain.

21 . A method as in claim 19 , wherein the region of the body comprises an ischemic limb.

22 . A method as in claim 19 , wherein the altering of the portion of the neural pathway increases perfusion to a portion of a peripheral vascular system affected by a peripheral vascular disease.

23 . A method as in claim 15 , wherein the altering of the portion of the neural pathway alleviates sympathetically mediated pain or sympathetically maintained pain.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 3, 2015
From: SPINAL MODULATION LLC
To: ST. JUDE MEDICAL LUXEMBOURG HOLDINGS SMI S.A.R.L. ("SJM LUX SMI")
Reel/Frame 037199/0142 →
CHANGE OF NAME Recorded Nov 20, 2015
From: SPINAL MODULATION, INC.
To: SPINAL MODULATION LLC
Reel/Frame 037150/0872 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2012
From: KIM, DANIEL H.
To: THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Reel/Frame 028556/0574 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2012
From: KRAMER, JEFFERY M.; IMRAN, MIR A.
To: SPINAL MODULATION, INC.
Reel/Frame 028556/0801 →